Agreements regarding study management, data sharing, investigational new drug possessorship, and new drug application filing responsibilities need to be worked out
Consistency is key for liver and skin health
It now includes oral GLP-1 drugs, amylin combinations, dual agonists, triple agonists, long-acting platforms, and differentiated assets designed for durability, tolerability, access, or broader metabolic indications
NAFLD is a complex disease
Our precision testing reveals what is actually happening beneath the surface, providing the objective data needed to differentiate between fat loss and vital lean muscle preservation
Retatrutide is designed to activate three hormone receptor pathways involved in appetite, glucose handling, and energy balance